Bloomberg Surveillance: Bloomberg BNA's Eleanor Tyler on pharma

Bloomberg Surveillance: Bloomberg BNA's Elean...

Suivant

Surveillance: The Covid Economy With Tooze

Adam Tooze, Columbia University Professor and Author, "Shutdown: How Covid Shook the World Economy", discusses the Covid crisis and the stalled recovery amid the virus’s resurgence. Megan Greene, Harvard Kennedy School Senior Fellow, says she is not worried about runaway inflatio ...  Afficher plus

Surveillance: Jobs Day Miss With Walsh

Marty Walsh, U.S. Labor Secretary, discusses the disappointing U.S. jobs report. Priya Misra, TD Securities Global Head of Rates Strategy, says the U.S. Economic recovery will continue to come in fits and starts. Jeff Rosenberg, BlackRock Senior Portfolio Manager of Systematic Mu ...  Afficher plus

Épisodes Recommandés

Despite All the Noise, PPE Is Only 1% of 3M's Bottom Line
The Tape

Karen Ubelhart, Senior Industrials analyst for Bloomberg Intelligence, on 3M and Caterpillar earnings. Ellen Wald, President of Transversal Consulting and a Bloomberg Opinion contributor, on why the oil crisis will spill over into midstream companies. Jim Paulsen, Chief Investmen ...  Afficher plus

Eli Lilly CEO Dave Ricks Talks Fighting Obesity, Developing New Drugs
Bloomberg Talks

Eli Lilly CEO Dave Ricks says the company is working on expanding its medicine supply as the global obesity rate increases. Speaking with Bloomberg's Caroline Hyde at the Economic Club of New York, the head of the pharma giant says that they are looking to create an oral tablet i ...  Afficher plus

Big Tech Unlikely To Truly Challenge Wall Street: Ex-OCC Chair
The Tape

Keith Noreika, Former Acting Comptroller of the Currency, discusses banking charters for tech firms, outlook for changes to the banking industry, and bitcoin as a currency.Max Nisen, Bloomberg Gadfly columnist covering health care, on biotech M&A, and what to expect from the big ...  Afficher plus

Gilead Virus Treatment Is Promising But No Silver Bullet Yet
The Tape

Sam Fazeli, Director of Research: EMEA for Bloomberg Intelligence, on Gilead's positive trial for a potential coronavirus treatment. Lisa Shalett, Chief Investment Officer: Wealth Management for Morgan Stanley, discusses why she wants clients to avoid S&P indices and to actively ...  Afficher plus